Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Aspirin Therapy in Primary Cardiovascular Disease Prevention
- Increased Risk for Stroke With Chronic Kidney Disease and Hypoglycemia
- Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
- Prognostic Value of Fasting vs Non-Fasting LDL Levels on Long-Term Mortality
- NSAIDs and Cardiovascular Outcomes in Women
- Extended-Release Niacin With Laropiprant in High-Risk Patients
- Aldosterone-Renin Ratio in the Assessment of Primary Aldosteronism
- Ethnic-Specific Obesity Cutoffs for Diabetes Risk
- Statins and the Risk for Diabetes
- Epidemiological Ramifications of Diagnosing Diabetes With HbA1c Levels